(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 190.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,904.13%.
Entera Bio's earnings in 2025 is -$10,781,000.On average, 3 Wall Street analysts forecast ENTX's earnings for 2025 to be -$14,967,804, with the lowest ENTX earnings forecast at -$14,380,831, and the highest ENTX earnings forecast at -$15,408,033.
In 2026, ENTX is forecast to generate -$31,338,839 in earnings, with the lowest earnings forecast at -$30,109,865 and the highest earnings forecast at -$32,260,570.